MIR4285

Across TCGA pan-cancer cohorts, MIR4285 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR4285 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR4285 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4285 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.

ACC, LUAD, and LUSC are the cancer types where MIR4285 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.182	0.820	<.001	108	view →
LUAD	OS	Tertile	III,IV	0.955	0.571	.003	66	view →
LUSC	DFS	Tertile	II,III,IV	0.202	0.416	.002	63	view →
COAD	OS	Tertile	All	0.661	0.887	<.001	60	view →
LAML	DFS	Quartile	All	0.740	0.355	<.001	48	view →
KIRC	DFS	Tertile	III,IV	0.348	0.511	.012	39	view →
LIHC	OS	Tertile	All	0.557	0.794	.008	33	view →
SKCM	OS	Tertile	IV	0.323	0.804	<.001	30	view →
MESO	OS	Tertile	II,III,IV	0.195	0.577	.023	27	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	21	view →
ESCA	DFS	Quartile	III,IV	0.630	0.288	.007	10	view →
PCPG	OS	Tertile	All	0.916	1.000	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR4285–ACC (OS)

Open the ACC breakdown →